294 related articles for article (PubMed ID: 15555923)
1. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation.
Deloulme JC; Raponi E; Gentil BJ; Bertacchi N; Marks A; Labourdette G; Baudier J
Mol Cell Neurosci; 2004 Dec; 27(4):453-65. PubMed ID: 15555923
[TBL] [Abstract][Full Text] [Related]
2. Spatial and temporal expression of S100B in cells of oligodendrocyte lineage.
Hachem S; Aguirre A; Vives V; Marks A; Gallo V; Legraverend C
Glia; 2005 Aug; 51(2):81-97. PubMed ID: 15782413
[TBL] [Abstract][Full Text] [Related]
3. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage.
Raponi E; Agenes F; Delphin C; Assard N; Baudier J; Legraverend C; Deloulme JC
Glia; 2007 Jan; 55(2):165-77. PubMed ID: 17078026
[TBL] [Abstract][Full Text] [Related]
4. Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells.
Nielsen JA; Berndt JA; Hudson LD; Armstrong RC
Mol Cell Neurosci; 2004 Jan; 25(1):111-23. PubMed ID: 14962745
[TBL] [Abstract][Full Text] [Related]
5. Calcium receptor expression and function in oligodendrocyte commitment and lineage progression: potential impact on reduced myelin basic protein in CaR-null mice.
Chattopadhyay N; Espinosa-Jeffrey A; Tfelt-Hansen J; Yano S; Bandyopadhyay S; Brown EM; de Vellis J
J Neurosci Res; 2008 Aug; 86(10):2159-67. PubMed ID: 18438915
[TBL] [Abstract][Full Text] [Related]
6. Directing human neural stem/precursor cells into oligodendrocytes by overexpression of Olig2 transcription factor.
Maire CL; Buchet D; Kerninon C; Deboux C; Baron-Van Evercooren A; Nait-Oumesmar B
J Neurosci Res; 2009 Nov; 87(15):3438-46. PubMed ID: 19739249
[TBL] [Abstract][Full Text] [Related]
7. The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor.
Garwood J; Garcion E; Dobbertin A; Heck N; Calco V; ffrench-Constant C; Faissner A
Eur J Neurosci; 2004 Nov; 20(10):2524-40. PubMed ID: 15548197
[TBL] [Abstract][Full Text] [Related]
8. The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2.
Terada N; Baracskay K; Kinter M; Melrose S; Brophy PJ; Boucheix C; Bjartmar C; Kidd G; Trapp BD
Glia; 2002 Dec; 40(3):350-9. PubMed ID: 12420314
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.
Padovani-Claudio DA; Liu L; Ransohoff RM; Miller RH
Glia; 2006 Oct; 54(5):471-83. PubMed ID: 16886211
[TBL] [Abstract][Full Text] [Related]
10. Olig gene function in CNS development and disease.
Ligon KL; Fancy SP; Franklin RJ; Rowitch DH
Glia; 2006 Jul; 54(1):1-10. PubMed ID: 16652341
[TBL] [Abstract][Full Text] [Related]
11. Large-scale generation of highly enriched neural stem-cell-derived oligodendroglial cultures: maturation-dependent differences in insulin-like growth factor-mediated signal transduction.
Broughton SK; Chen H; Riddle A; Kuhn SE; Nagalla S; Roberts CT; Back SA
J Neurochem; 2007 Feb; 100(3):628-38. PubMed ID: 17263792
[TBL] [Abstract][Full Text] [Related]
12. Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis.
Luyt K; Váradi A; Durant CF; Molnár E
J Neurochem; 2006 Oct; 99(2):641-56. PubMed ID: 16836654
[TBL] [Abstract][Full Text] [Related]
13. ATF5 regulates the proliferation and differentiation of oligodendrocytes.
Mason JL; Angelastro JM; Ignatova TN; Kukekov VG; Lin G; Greene LA; Goldman JE
Mol Cell Neurosci; 2005 Jul; 29(3):372-80. PubMed ID: 15950153
[TBL] [Abstract][Full Text] [Related]
14. Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death.
Ceruti S; Viganò F; Boda E; Ferrario S; Magni G; Boccazzi M; Rosa P; Buffo A; Abbracchio MP
Glia; 2011 Mar; 59(3):363-78. PubMed ID: 21264945
[TBL] [Abstract][Full Text] [Related]
15. Sequence of oligodendrocyte development in the human fetal telencephalon.
Jakovcevski I; Zecevic N
Glia; 2005 Mar; 49(4):480-91. PubMed ID: 15578660
[TBL] [Abstract][Full Text] [Related]
16. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
Islam MS; Tatsumi K; Okuda H; Shiosaka S; Wanaka A
Neurochem Int; 2009; 54(3-4):192-8. PubMed ID: 19070638
[TBL] [Abstract][Full Text] [Related]
17. NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells.
Baracskay KL; Kidd GJ; Miller RH; Trapp BD
Glia; 2007 Aug; 55(10):1001-10. PubMed ID: 17503442
[TBL] [Abstract][Full Text] [Related]
18. Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse.
Shimizu T; Tanaka KF; Takebayashi H; Higashi M; Wisesmith W; Ono K; Hitoshi S; Ikenaka K
J Neurosci Res; 2013 Feb; 91(2):178-86. PubMed ID: 23172790
[TBL] [Abstract][Full Text] [Related]
19. Invivo insulin deficiency as a potential etiology for demyelinating disease.
Gong X; Xie Z; Zuo H
Med Hypotheses; 2008 Sep; 71(3):399-403. PubMed ID: 18621485
[TBL] [Abstract][Full Text] [Related]
20. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice.
Hirahara Y; Bansal R; Honke K; Ikenaka K; Wada Y
Glia; 2004 Feb; 45(3):269-77. PubMed ID: 14730700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
